Empagliflozin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Linagliptin and Metformin: A 24-Week Randomized, Double-Blind, Parallel-Group Trial. (Q51275606)
Jump to navigation
Jump to search
scientific article published on 2 December 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Empagliflozin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Linagliptin and Metformin: A 24-Week Randomized, Double-Blind, Parallel-Group Trial. |
scientific article published on 2 December 2016 |
Statements
1 reference
Empagliflozin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Linagliptin and Metformin: A 24-Week Randomized, Double-Blind, Parallel-Group Trial. (English)
1 reference
Eirik Søfteland
1 reference
Juris J Meier
1 reference
Bente Vangen
1 reference
Robert Toorawa
1 reference
Mario Maldonado-Lutomirsky
1 reference
Uli C Broedl
1 reference
2 December 2016
1 reference
1 reference
40
1 reference
201-209
1 reference
2
1 reference
Identifiers
1 reference
1 reference